APUS — Apimeds Pharmaceuticals US, Inc
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 3.57 |
| Market cap (USD) | 5,387,548 |
| P/E | -5.02 |
| ROE (%) | -139.58 |
| Net profit margin (%) | 0 |
| Revenue growth (%) | Not available |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Apimeds Pharmaceuticals US, Inc
Available company fundamentals for APUS in Drug Manufacturers - Specialty & Generic. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.